Recent news on Valsartan

Valsartan, Hydrochlorothiazide Combo Works Better Than Valsartan ...  -  25 May 2007
DG NewsHis group compared the combination of valsartan/HCTZ 160/12.5 mg force-titrated to 160/25 mg at week 2 and 320/25 mg at week 4 versus monotherapy with

New developments from Novartis Pharmaceuticals Corporation ...  -  25 May 2007
Therapeutics Daily (subscription) (press release),...and the leading therapy Diovan(R) (valsartan) -- experienced greater reductions in blood pressure levels than those using either agent alone.

Valsartan Is a Prudent Choice in Young Hypertensives: Presented at ASH  -  May 21, 2007
DG NewsCHICAGO, IL -- May 21, 2007 -- Valsartan appears to be safe and effective for the treatment of hypertension in children and teenagers, researchers announced

ASH: More Proves Better in Treating Hypertension  -  May 23, 2007
MedPage Today,The combination of the calcium channel blocker amlodipine and an angiotensin-receptor blocker -- either valsartan or olmesartan -- resulted in a greater

Analysis: Combos best for blood pressure?  -  May 22, 2007
United Press InternationalIn two trials, doctors combined amlodipine with the angiotension receptor blockers valsartan or olmesartan and came up with similar conclusions: The

Exforge Helps Vast Majority of Patients Effectively Control Their ...  -  May 21, 2007
PharmaLive.com (press release),The efficacy of Exforge, which combines the angiotensin receptor blocker (ARB) valsartan (Diovan®) and the calcium channel blocker (CCB) amlodipine in one

First Controlled Large-Scale Intervention Angiotensin Receptor ...  -  Apr 26, 2007
CNW Telbec (Communiqués de presse),Unprecedented Evidence for the Effectiveness of Hypertension Treatment Valsartan in Preventing Cardiovascular Events in Japanese Patients >> TOKYO,

Unprecedented Evidence for the Effectiveness of Hypertension ...  -  Apr 26, 2007
PR Newswire (press release),In the study, valsartan was added to conventional therapy to control blood pressure and protect against cardiovascular events and stroke.

Novartis says Exforge 'successful' in trials vs single medicines  -  May 21, 2007
Forbes,Exforge is a single-tablet combination of two of the world's most commonly prescribed high blood pressure medicines, angiotensin receptor blocker valsartan

Sales in rest of Europe help Ipsen overcome French decline  -  May 4, 2007
Pharma Times (subscription),The antihypertensive drugs Nisis (valsartan) and Nisisco (valsartan and hydrochlorothiazide) contributed 11.8 million euros, up 7.1% "despite high

New Data Highlights Potential of SPP100 (Tekturna) as Gold ...  -  May 21, 2007
PharmaLive.com (press release),Dual renin system intervention with the combination of aliskiren and valsartan provides clinically significant additional blood pressure reductions and

APS: First Controlled Large-Scale Intervention Angiotensin .......  -  Apr 26, 2007
ANP Pers Support,...valsartan arm in reducing the risk of cardiovascular events as well as stroke. Because of. to lower blood pressure while being highly protective of end

Landmark study shows 40% reduction in cardiovascular events and stroke  -  Apr 30, 2007
CNW Telbec (Communiqués de presse),Diovan Approved in Canada in 1997, Diovan (valsartan) is a highly selective angiotensin II ATI receptor blocker (ARB), and is indicated in Canada for the

Novartis off to a flyer in 2007 thanks to Diovan and Gleevec  -  Apr 24, 2007
Pharma Times (subscription),Pharmaceutical revenues climbed 17% to $5.92 billion, with sales of the antihypertensives Diovan (valsartan) and Lotrel (benazepril and amlodipine) sales

Novartis' 1st-qtr 2007 profit up 11% to $2.17B on strong sales of ...  -  Apr 24, 2007
Therapeutics Daily (subscription) (press release),...as total revenues jumped 18% to $9.82 billion, boosted by strong sales of its cancer drugs and the blood pressure medication Diovan (valsartan).

Aliskiren and Valsartan Work in Concert to Get Blood Pressure ...  -  Mar 28, 2007
DG News..."Aliskiren and valsartan are both effective antihypertensives, but they function very differently," said Suzanne Oparil, MD, professor of medicine,

Dual Renin System Blocking Drug Combo Provides Additional Blood ...  -  Apr 3, 2007
Medical News Today (press release),Aliskiren and valsartan have both been shown to have anti-hypertensive effects when given individually, but this is the first study that pairs the two in

New combination treatment for hypertension  -  Apr 2, 2007
Healthcare RepublicNovartis has launched Exforge (amlodipine besylate + valsartan) for the treatment of hypertension, not adequately controlled by amlodipine or valsartan

Lowering Blood Pressure Improves Diastolic Dysfunction In ...  -  Apr 3, 2007
Science Daily (press release)In this study, known as the VALIDD (The VALsartan In Diastolic Dysfunction) trial, conducted at 41 centers in the United States and Canada,

Tekturna, First New Type of High Blood Pressure Medicine in a ...  -  Apr 5, 2007
Therapeutics Daily (subscription) (press release),...and the leading therapy Diovan(R) (valsartan) -- experienced greater reductions in blood pressure levels than those using either agent alone.

Tekturna®, First New Type Of High Blood Pressure Medicine In A ...  -  Apr 2, 2007
Medical News Today (press release),..."The Direct Renin Inhibitor Aliskiren in Combination With the Angiotensin Receptor Blocker Valsartan Provides Additional Blood Pressure-Lowering Effects

Lotus Pharmaceuticals Releases Audited Annual Report With $36 ...  -  Apr 17, 2007
Primenewswire (press release),The significant increase in tangible product revenues is mainly attributed to continued strong sales of our best selling product, Valsartan Capsules,

Low red blood cell count requires transfusion  -  Apr 1, 2007
DetNews.com,One is valsartan, the Diovan part. It blocks the action of body chemicals that bring on artery constriction. Constricted arteries raise blood pressure.

Novartis antihypertensive combination works well  -  Mar 28, 2007
Pharma Times (subscription),It revealed that half the patients taking both the recently-approved Tekturna (aliskiren) and the more established Diovan (valsartan) saw a reduction in

Ipsen results sound but western Europe market is a worry  -  Feb 2, 2007
Pharma Times (subscription),The antihypertensive drugs Nisis (valsartan) and Nisisco (valsartan and hydrochlorothiazide) contributed 50.7 million euros, up 22% which "was well above

Pharmacopeia tout 2-for-1 cardiovascular drug  -  Feb 19, 2007
DrugResearcher.com,Other than Avapro, other angiotensin II receptor blockers currently approved are Diovan (valsartan) from Novartis and Cozaar (losartan) from Merck & Co.

New Market Research 'The Cardiovascular Market Outlook to 2011 ...  -  Feb 1, 2007
American Digital Networks (press release),...-Two key anti-hypertensives are forecast to launch in 2007: Novartis' Rasilez (aliskiren) and Exforge (valsartan plus amlodipine).

Current and Future Market for Cardiovascular Drugs: Market Size ...  -  Jan 30, 2007
PharmaLive.com (press release),Two key anti-hypertensives are forecast to launch in 2007:Novartis' Rasilez (aliskiren) and Exforge (valsartan plus amlodipine).Exforge gained FDA approval

Exforge® approved in Europe as powerful new blood pressure therapy ...  -  18 Jan 2007
WebWire (press release),Exforge combines in one tablet the power of the two most commonly prescribed branded hypertension medicines - Diovan® (valsartan) and Norvasc® (amlodipine

Novartis Strategic Healthcare Portfolio Drives Sustained Strong ...  -  18 Jan 2007
PharmaLive.com (press release),Exforge[1], a single tablet with the two most prescribed branded anti-hypertension medicines - the angiotensin receptor blocker valsartan and the calcium

/CORRECTION -- Novartis Pharmaceuticals Corporation/  -  Dec 27, 2006
Drug Newswire (press release),...more than 5000 patients showed that Exforge significantly lowered blood pressure compared to placebo, or amlodipine besylate or valsartan alone.

Will more complete inhibition of the RAAS with angiotensin ...  -  Jan 3, 2007
HeartZine,A number of other large-scale studies on valsartan and related ARBs are expected to provide definitive results to answer open questions about the role of

Low libido from blood pressure drug?  -  Jan 16, 2007
Newsday,Some physicians report that ACE inhibitors (such as enalapril or lisinopril) or ARBs (such as losartan or valsartan) may be less likely to affect sexual

Exforge(R) Receives US Regulatory Approval as a New and Highly ...  -  Dec 21, 2006
PR Newswire (press release),Exforge offers in one tablet the complementary actions of valsartan and amlodipine besylate, two of the most prescribed branded antihypertensive medicines

Exforge(R) Receives US Regulatory Approval As A New And Highly ...  -  Dec 24, 2006
Medical News Today (press release),Exforge combines in one tablet the two most commonly prescribed hypertension medicines in their categories -- Diovan(R) (valsartan) and Norvasc(R)**

/CORRECTION -- Novartis Pharmaceuticals Corporation/  -  Dec 22, 2006
Earthtimes.org...more than 5000 patients showed that Exforge significantly lowered blood pressure compared to placebo, or amlodipine besylate or valsartan alone.

Digoxin dose chart removes guesswork  -  Dec 15, 2006
Science Daily (press release)5 New England Journal of Medicine demonstrate that adding the angiotensin II receptor blocker (ARB) valsartan to ... > full story

Exforge receives positive EU regulatory opinion supporting ...  -  Dec 14, 2006
Therapeutics Daily (subscription) (press release),Novartis announced a positive opinion supporting European Union approval of Exforge (valsartan/ amlodipine besylate) as a new treatment option for patients

Exforge receives positive EU regulatory opinion supporting ...  -  Dec 14, 2006
Therapeutics Daily (subscription) (press release),2006 DEC 21 - (NewsRx.com) -- Novartis announced a positive opinion supporting European Union approval of Exforge (valsartan/ amlodipine besylate) as a new

ACNP: Hypertension Drugs May Block Alzheimer's  -  Dec 6, 2006
Psychiatric Times,In a parallel study, Dr. Pasinetti and colleagues treated five-month-old TG2576 mice with Diovane (valsartan) at 10 mg/kg. At that age, the mice have begun

Exforge(R) Receives US Regulatory Approval as a New and Highly ...  -  Dec 21, 2006
PR Newswire (press release),Exforge offers in one tablet the complementary actions of valsartan and amlodipine besylate, two of the most prescribed branded antihypertensive medicines

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...  -  Nov 29, 2006
Medical News Today (press release),Exforge is the first medicine to combine the angiotensin receptor blocker (ARB) valsartan (Diovan) and the calcium channel blocker (CCB) amlodipine besylate

Foro de Shell Security - Seguridad informática  Oct 27, 2006
...growth factors. Little valsartan vidence points to a defective microenvironment as a cause of. apla valtrex tic anemia. In patients ... -Shell Security, LG Life Sciences, Novartis Korea sign comarketing agreement for Co ...  Oct 19, 2006
Diovan," Novartis' hypertension treatment. CoDiovan is a combination of valsartan and hydrochlorothiazide. LG Life Sciences plans ... -Therapeutics Daily (subscription) (press release), Novartis Delivers Dynamic Sales and Earnings Growth in the First ...  Oct 18, 2006
Exforge(1), a single tablet containing the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan, has been submitted for US and ... -Market Wire (press release) Cardiovascular benefit of adding valsartan to optimal therapy in ...  Sep 11, 2006
Barcelona, Spain - The addition of the angiotensin-receptor blocker valsartan (Diovan, Novartis) in a cohort of Japanese patients with optimized medical ... -TheHeart.Org

Valsartan Plus Diuretic Normalizes Blood Pressure Faster Than ...  Sep 6, 2006
BARCELONA, SPAIN -- September 6, 2006 -- Hypertensive patients who are treated with the angiotensin receptor blocker (ARB) valsartan plus a diuretic will ... -DG News

Cardiovascular Events Reduced in Japanese JIKEI Study With ...  Sep 5, 2006
BARCELONA, SPAIN -- September 5, 2006 -- Addition of the angiotensin receptor blocker (ARB) valsartan to an antihypertensive regimen markedly reduced adverse ... -DG News

One of the largest Japanese cardiovascular trials confirms ...  Sep 5, 2006
...trial of angiotensin receptor blockade in Japanese patients has confirmed that the cardiovascular protective effects of the drug valsartan is greater than to ... -News-Medical.net

EUROPEAN COMMISSION GRANTS APPROVAL FOR ADDING HIGH DOSE COAPROVEL ...  Sep 5, 2006
...treatment with irbesartan 150 mg/HCTZ 12.5 mg, this combination was superior in its lowering effect on arterial blood pressure compared to the valsartan 80 mg ... -ITNews

Novartis' Diovan cuts stroke, other risks, Japanese study finds  Sep 5, 2006
On top of that, patients were given either Diovan, also known as valsartan, or high-blood pressure treatments that belong to other classes of therapy. ... -MarketWatch

Medicine prices a bitter pill to swallow  Sep 16, 2006
Anti-BP drug valsartan 80 mg, for example, is sold at Rs 69 for ten tablets by one company and at almost 495 per cent more ~ at Rs 410 ~ by another. ... -The Statesman

Canadian Web Sites Selling Counterfeit Drug Products  Sep 1, 2006
...products have found the following drugs from these Canadian sites to be counterfeit: Lipitor (atorvastatin calcium), Diovan (valsartan), Actonel (risedronate ... -Facts and Comparisons

Research and Markets: A Fourth Division for Novartis Under the ...  Sep 1, 2006
These include: Diovan (valsartan), Glivec/Gleevec (imatinib), Zelmac/Zelnorm (tegaserod), Femara (letrozole) and Zometa (zoledronate). ... -International News Service

BP-lowering effects of aliskiren are additive to amlodipine ...  Sep 4, 2006
...cardiovascular events and may have effects additive to hydrochlorothiazide (HCTZ), and to a much lesser extent, the angiotensin receptor blocker valsartan. ... -TheHeart.Org

Novartis' Diovan Cuts Stroke, Other Risks-Japanese Study  Sep 5, 2006
...failure, who were on standard treatment. On top of that, patients were given either Diovan, also known as valsartan, or high-blood ... -Therapeutics Daily (subscription)

Hypertension :: Novartis' Exforge, valsartan approved in Europe ...  -  Nov 17, 2006
SpiritIndia,Novartis announced today a positive opinion supporting European Union approval of Exforge® (valsartan/ amlodipine besylate) as a new treatment option for ...

Study Shows Valsartan Reduced Urinary Protein Excretion in ...  -  Nov 20, 2006
DG News20, 2006 -- In patients with high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan® (valsartan) significantly reduced urinary ...

ACNP: Hypertension Drugs May Block Alzheimer's  -  Dec 6, 2006
MedPage Today,...said. In a parallel study, Dr. Pasinetti and colleagues treated five-month-old TG2576 mice with Diovane (valsartan) at 10 mg/kg. At ...

Committee for Medicinal Products for Human Use Summary of Positive ...  -  Nov 17, 2006
PharmaLive.com (press release),...tablet intended for treatment of essential hypertension in patients whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy. ...

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New ...  -  Nov 29, 2006
Medical News Today (press release),US regulatory decisions are also expected for Tekturna (aliskiren), a renin inhibitor for hypertension, and Exforge (valsartan and amlodipine), a single-tablet ...

Exforge Receives Positive European Union Regulatory Opinion ...  -  Nov 17, 2006
PharmaLive.com (press release),17, 2006 - Novartis announced today a positive opinion supporting European Union approval of Exforge® (valsartan/ amlodipine besylate) as a new treatment ...

Novartis' blood pressure drug helps with diabetes  -  Nov 13, 2006
ReutersIt was was the first to test the safety of Diovan, known generically as valsartan, in a 640-milligram dose, which is not currently approved. ...

Study shows Diovan reduced urinary protein excretion in patients ...  -  Nov 13, 2006
News-Medical.net,In patients with high blood pressure and type 2 diabetes, the blood pressure-lowering medication Diovan (valsartan) significantly reduced urinary protein ...

Full Text  Aug 3, 2006
...of biologically active and functional molecules (1–4). Its importance is reflected in the immense economic value of pharmaceuticals including Valsartan (5, 6 ... -Science Magazine (subscription)

Updating European Guidelines for the Management of Hypertension  Jul 17, 2006
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial showed that patients whose blood pressure was controlled to < 140/90 mm Hg had much less ... -Medscape (subscription)

Incidence Of Atrial Fibrillation Significantly Reduced By ...  Jul 16, 2006
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT). ... -Medical News Today

Clinical Trials Update: July 14, 2006  Jul 14, 2006
This is a clinical research study to find out if the combination of the drugs valsartan and amlodipine is safe and effective for African-Americans with moderate ... -Forbes

Novartis Generates Strong Sales and Earnings Growth in the First ...  Jul 17, 2006
Exforge1, a one-tablet combination of the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan, showed in the first Phase III data ... -PharmaLive.com

Treating heart failure  Jul 8, 2006
Examples of useful ARBs for heart failure which have been shown to be beneficial in some patients include valsartan, candesartan, and losartan. ... -Malaysia Star

Bull’s-eye on Blockbusters  Jul 12, 2006
...billion in 2005. A leader in this class is Diovan, which is composed of valsartan and is marketed by Novartis. Rasilez could be ... -Med Ad News (subscription)



(PZ) Genesis Equity Partners Launches Lotus Pharmaceuticals for ' ...  Apr 3, 2006
Valsartan Capsules, among Lotus's best-selling products, is a medication for primary hypertension or high blood pressure. Valsartan ... - Houston Chronicle

Dumaguing: How sweet is your heart?  Apr 2, 2006
AVIGATOR (Nateglinide and Valsartan in IGT Outcomes Research trial) is a massive global effort involving about 790 investigators in 40 countries. ... - Sun.Star

(PZ) Genesis Equity Partners Acquires Interest in Chinese ...  Mar 21, 2006
Among Liang Fang's best selling products, Valsartan Capsules are a medicine for primary hypertension or high blood pressure. Valsartan ... - Houston Chronicle



Novartis files combo blood pressure drug in EU  Mar 3, 2006
Exforge (amlodipine and valsartan), is a fixed-dose combination of the two most-prescribed anti-hypertensives in the marketplace, according to Novartis. ... - Pharma Times (subscription),

Novartis files for EU approval for Exforge blood pressure tablet  Mar 2, 2006
Exforge, a combination of the calcium channel blocker amlodipine and the angiotensin receptor blocker valsartan, has been shown in clinical trials involving ... - Forbes

Attempts to Recruit Stem Cells for Repair of Acute Myocardial ...  Feb 28, 2006
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation. 2005;111:3411-3419. ... - Journal of American Medical Association (subscription),

SCHWARZ PHARMA /Full Year Report 2005  Feb 17, 2006
This growth was particularly driven by the promoted drugs Rifun® (pantoprazole; +33%), Atmadisc® (fluticasone/salmeterol; +22%) and Provas® (valsartan; +10 ... - PharmaLive.com,

Novartis' sales climb 14% in fourth quarter  Jan 19, 2006
Meanwhile, looking at the performance of individual products, growth in the pharma division was once again driven by Diovan (valsartan) for high blood pressure ... - Pharma Times (subscription)

Jubilant Organosys Ltd.  Jan 18, 2006
...various departments. During the quarter, the company filed DMF for Azithromycin Monohydrate, Valsartan and Tramadol Hydrochloride. The ... - India Infoline.com

Novartis will file Galvus, Rasilez this quarter  Jan 20, 2006
Other regulatory filings scheduled for 2006 will include Exforge, a combination of amlodipine and valsartan for high blood pressure, Lucentis (ranibizumab) for ... - Pharma Times (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional